189 related articles for article (PubMed ID: 27875373)
21. The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50.
Uchida T; Hagihara M; Hua J; Inoue M
Leuk Res; 2017 Feb; 53():35-38. PubMed ID: 28013105
[TBL] [Abstract][Full Text] [Related]
22. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
Alkharabsheh O; Al-Kali A; Saadeh S; He R; Viswanatha D; Greipp P; Reichard K; Shah M; Gangat N; Patnaik M; Hogan W; Litzow M; Alkhateeb H; Nguyen PL
Am J Hematol; 2018 Nov; 93(11):E355-E357. PubMed ID: 30074268
[No Abstract] [Full Text] [Related]
23. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
24. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).
Bennett JM; Tuechler H; Aul C; Strupp C; Germing U
Leuk Res; 2016 Aug; 47():63-9. PubMed ID: 27258735
[TBL] [Abstract][Full Text] [Related]
25. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
26. Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature.
Atkinson J; Hrisinko MA; Weil SC
Blood Rev; 1992 Dec; 6(4):204-14. PubMed ID: 1486289
[TBL] [Abstract][Full Text] [Related]
27. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
[TBL] [Abstract][Full Text] [Related]
28. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
Bennett JM
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
[TBL] [Abstract][Full Text] [Related]
29. [Erythroleukemias. Recategorization according to the World Health Organization's criteria].
Peruzzo LB; Bertone MC; Mathey MD; Rossi JG; Baialardo EM; Felice MS
Medicina (B Aires); 2019; 79(1):1-5. PubMed ID: 30694182
[TBL] [Abstract][Full Text] [Related]
30. Essential thrombocythemia terminating in pure erythroleukemia.
Kreft A; Burg J; Fischer T; Kirkpatrick CJ
Am J Hematol; 2004 Oct; 77(2):140-3. PubMed ID: 15389906
[TBL] [Abstract][Full Text] [Related]
31. Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance.
Pourabdollah M; Chang H
Blood; 2017 Feb; 129(7):918. PubMed ID: 28209754
[No Abstract] [Full Text] [Related]
32. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.
Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH
Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998
[TBL] [Abstract][Full Text] [Related]
33. Erythroleukemia.
Gupta PC; Tayal A; Narayan S; Logani KB; Aneja S
Indian Pediatr; 1991 Apr; 28(4):422-5. PubMed ID: 1752664
[No Abstract] [Full Text] [Related]
34. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
[TBL] [Abstract][Full Text] [Related]
35. Erythroleukemia: a clinco-hematological review of four cases.
Batra VV; Karan AS; Saxena R
Indian Pediatr; 2004 Jun; 41(6):587-90. PubMed ID: 15235164
[TBL] [Abstract][Full Text] [Related]
36. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
37. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
Wong E; Juneja S
Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
[TBL] [Abstract][Full Text] [Related]
39. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
[TBL] [Abstract][Full Text] [Related]
40. Hematopathological features of acute erythremia (morbus Di Guglielmo). A contribution to the classification and differential diagnosis of erythroid neoplasias.
Griesser GH; Horny HP
Acta Haematol; 1987; 77(4):193-7. PubMed ID: 3115028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]